You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Investigational Drug Information for Fluzoparib

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Fluzoparib?

Fluzoparib is an investigational drug.

There have been 51 clinical trials for Fluzoparib. The most recent clinical trial was a Phase 1 trial, which was initiated on August 19th 2020.

The most common disease conditions in clinical trials are Breast Neoplasms, Ovarian Neoplasms, and Carcinoma, Ovarian Epithelial. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Fudan University, and Tianjin Medical University Cancer Institute and Hospital.

There are two US patents protecting this investigational drug and twenty-one international patents.

Recent Clinical Trials for Fluzoparib
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast CancerFudan UniversityPhase 3
Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue SarcomaFujun ZhangPhase 2
Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast CancerJiangsu HengRui Medicine Co., Ltd.Phase 2

See all Fluzoparib clinical trials

Clinical Trial Summary for Fluzoparib

Top disease conditions for Fluzoparib
Top clinical trial sponsors for Fluzoparib

See all Fluzoparib clinical trials

US Patents for Fluzoparib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fluzoparib ⤷  Try a Trial Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof Jiangsu Hansoh Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, CN) ⤷  Try a Trial
Fluzoparib ⤷  Try a Trial Methods of using phthalazinone ketone derivatives Jiangsu Hansoh Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, CN) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fluzoparib

Drugname Country Document Number Estimated Expiration Related US Patent
Fluzoparib Australia AU2011288876 2030-08-09 ⤷  Try a Trial
Fluzoparib Brazil BR112013002220 2030-08-09 ⤷  Try a Trial
Fluzoparib Canada CA2806324 2030-08-09 ⤷  Try a Trial
Fluzoparib China CN102372716 2030-08-09 ⤷  Try a Trial
Fluzoparib China CN102686591 2030-08-09 ⤷  Try a Trial
Fluzoparib European Patent Office EP2604610 2030-08-09 ⤷  Try a Trial
Fluzoparib Spain ES2582315 2030-08-09 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.